Stewart J F, Tattersall M H, Woods R L, Fox R M
Br Med J. 1979 Jun 9;1(6177):1530-3. doi: 10.1136/bmj.1.6177.1530.
Out of 1300 patients referred to a medical oncology unit, there were 87 with metastatic cancer in whom a primary tumour site was not evident from the history and after physical examination and chest radiography had been carried out. An analysis of the investigations performed in these patients and their results showed that in only eight of the 87 patients did non-surgical investigations at presentation determine the primary site. In two patients it was identified by diagnostic laparotomy, and in a further 13 clinical follow-up led to recognition of the primary tumour site before death. Few investigations should be performed in patients in whom the primary site is known since they have a low yield, and in our population identifying the primary tumour did not improve the outcome or alter management. Treatable tumours should be excluded, and this may be done in most cases by simple blood tests, particularly those measuring acid phosphatase activity and other tumour markers.
在转诊至肿瘤内科的1300例患者中,有87例患有转移性癌症,从病史、体格检查及胸部X线检查中均无法明确其原发肿瘤部位。对这些患者所做检查及其结果的分析显示,在这87例患者中,仅8例在初诊时通过非手术检查确定了原发部位。2例通过诊断性剖腹术得以确诊,另有13例经临床随访在患者死亡前明确了原发肿瘤部位。对于已知原发部位的患者,应尽量减少检查,因为检查结果的阳性率较低,而且在我们的研究人群中,确定原发肿瘤并不能改善预后或改变治疗方案。应排除可治疗的肿瘤,多数情况下通过简单的血液检查即可做到,尤其是检测酸性磷酸酶活性及其他肿瘤标志物的检查。